Lynparza (olaparib) is AstraZeneca's targeted cancer medicine. The event room is purple, with DNA-helix light frames along the walls and a "Test me, treat me" message on the main screen.
Round tables fill the ballroom, and the DNA motif connects the décor to the genetic-testing story behind the drug.
Stage and venue concept, 3D visualisation and production design.
